Capricor Therapeutics's total assets for Q1 2026 were $326.28M, a decrease of -8.33% from the previous quarter. CAPR total liabilities were $47.58M for the fiscal quarter, a -5.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.